Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1016/s2213-8587(13)70137-2

Type

Journal article

Journal

The lancet. Diabetes & endocrinology

Publication Date

11/2013

Volume

1

Pages

175 - 177

Addresses

Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK. Electronic address: amanda.adler@addenbrookes.nhs.uk.

Keywords

Humans, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Risk Assessment, Drug Approval, Product Surveillance, Postmarketing